πŸ”¬ Post argues that FOCI is undervalued compared to POET, highlighting FOCI's critical role as bottleneck for CPO volume ramp and main supplier to TSM and NVDA, expecting outperformance once institutions discover it

high convictionFirst mentioned May 14, 2026 at $20.57

Post argues that FOCI is undervalued compared to POET, highlighting FOCI's critical role as bottleneck for CPO volume ramp and main supplier to TSM and NVDA, expecting outperformance once institutions discover it.

Evidence & details
Evidence
  • +Mentioned that Ayar, Lightmatter, Lightelligence, and others have valuations of $5-15B+.
  • +Claimed that Sivers lasers likely power them all and are primary/sole source for a lot.
Catalysts
  • ⚑Potential market revaluation as Sivers' key role in the photonics ecosystem becomes more recognized.
Risks
  • βˆ’Technological competition or customer vertical integration could reduce Sivers' importance.

Chart

Post Timeline Β· 7 posts

new thesishigh

@yvesai0 Nah, I think $SIVE is still extremely undervalued relatively speaking. Ayar, Lightmatter, Lightelligence, celestial, and others all probably command $5-$15B+ valuations. Not even including small guys like $POET or pluggables like $JBL. Sivers lasers likely power them…

Thesis: Sivers lasers are undervalued relative to the high valuations of their customers (Ayar, Lightmatter, Lightelligence, etc.) because Sivers is likely the primary/sole source for many critical components…

noise

$POET and $IREN literally both won the Fake it Until you make it award. -> Grey area endless marketing of crap through influencers. -> Diluted retail enough to hoard tons of cash -> Cash is sets baseline Market Cap. Now $POET probably has around $830M pure cash from dilution…

Thesis: Post criticizes POET and IREN for using influencer marketing and dilution to raise cash, implying their valuations are artificial.

view on X β†—POET Β· IREN
new thesishigh

HOW DOES $POET ($3.14B) HAVE A HIGHER VALUATION THAN FOCI (3363, $3.1B)??? FOCI IS LITERALLY THE BOTTLENECK FOR CPO VOLUME RAMP AND MAIN SUPPLIER FOR $TSM AND $NVDA. High conviction Foci outperforms once institutions find this name. Also, can Foci management please pursue NAS…

Thesis: Post argues that FOCI is undervalued compared to POET, highlighting FOCI's critical role as bottleneck for CPO volume ramp and main supplier to TSM and NVDA, expecting outperformance once institutions…

view on X β†—POET Β· FOCI
new thesismedium

If you didn't know $POET is up 22% premarket on a $50m purchase from Lumilens. Scaling to $500m with a longer term framework. As mentioned in Sivers 2025 annual report: $POET is ramping up H2 2026 with $SIVE. Any demand from these midstream players back to $SIVE as the laser…

Thesis: POET's large purchase and scaling plans are highly bullish for Sivers as the laser chokepoint, with demand flowing back to SIVE.

thesis updatehigh

@AD14977 I've always said $POET is the most likely to get designed out down the road. They just buy lasers and package them... and $MRVL can just go directly to the laser source and do the same with some delays to their roadmap.

Thesis: POET is at risk of being designed out by MRVL because POET only buys and packages lasers, and MRVL can go directly to laser sources, causing delays to POET's roadmap.

new thesismedium

$MRVL cancelled $POET purchase orders after the CFO went out and violated NDA when getting angry. Ouch to Poet, down -46%, this is why I don’t like companies with single customer concentration risk. On the bright side for $POET holders they do have $420m cash buffering downside…

Thesis: Marvell cancelled POET purchase orders after CFO violated NDA, highlighting single customer concentration risk for POET.

thesis updatemedium

@InvestWithFelix Yep $POET is a massive beneficary. It’s more well known with Celestial. Even analysts miss though Poet’s light source for ELS comes from $SIVE. But huge for their whole ecosystem that Nvidia is validating it

Thesis: Nvidia's $2B investment in Marvell validates the optical fabric CPO ecosystem, benefiting POET and its light source supplier SIVE.

view on X β†—POET Β· SIVE
Current Price
$13.26
via cornerstones
Return from entry
-35.54%
entry May 14, 2026 @ $20.57
Signal-day returns
+7 days-27.95%
Thesis Lifecycle
πŸ“
updatedMar 30, 2026+1 conv

Rotation into CPO/ELS/SiPh supply chain for AI infrastructure supercycle, following previous rotation from memory to photonics. Heavily adding to SIVE, TSEM, SOI, AEHR, and POET as direct exposure to the next bottleneck resolution (optical interconnects).

source β†—
πŸ“
updatedMar 31, 2026-1 conv

Nvidia's $2B investment in Marvell validates the optical fabric CPO ecosystem, benefiting POET and its light source supplier SIVE.

source β†—
πŸ“
updatedMar 31, 2026+1 conv

SIVE is a critical light source for NVDA and MRVL's Celestial platform, making it a key beneficiary alongside POET.

source β†—
πŸ“
updatedApr 1, 2026

AI-driven photonics and advanced packaging supercycles are just beginning, with beneficiaries including SIVE, AAOI, AEHR, NBIS, AMKR, and POET.

source β†—
πŸ“
updatedApr 1, 2026-1 conv

Increased bullishness on the celestial ecosystem (POET, SIVE) due to NVDA's $2B deal with MRVL, indicating growth in the ecosystem.

source β†—
πŸ“
updatedApr 1, 2026+1 conv

Nvidia's $2B investment into Marvell's Celestial CPO program is catalyzing a photonics supercycle; upstream beneficiaries include POET (optical engines), SIVE (laser source), SOI/AXTI (substrates), and IQE (epiwafers), with supply shocks expected earlier than anticipated.

source β†—
πŸ“
updatedApr 1, 2026-1 conv

IQE has binary upside potential (5-10x) if restructuring and InP AI segments succeed; POET has low downside risk due to cash balance and upside if qualifies with partners beyond Celestial; AXTI could reach $10B market cap if it weaponizes its supply chain, otherwise current valuation is reasonable; AAOI could 4x in a year if execution succeeds.

source β†—
πŸ“
updatedApr 7, 2026

POET has low downside risk due to high cash balance relative to market cap, and is the sole source supplier of Marvell's Celestial, with potential for multi-billion valuation if customer diversification improves. SIVE has similar supply chain exposure at a lower market cap.

source β†—
πŸ“
updatedApr 19, 2026

Qualification cycles for POET and SIVE are long, preventing quick design-out. Multi-sourcing is expected over time but not in short term for 2028 volume ramp.

source β†—
πŸ“
updatedApr 19, 2026+1 conv

Supply chain mapping based on confirmed agreements provides high confidence in the investment thesis for $SIVE and $POET, with near-certainty for early production cycles.

source β†—
πŸ“
updatedApr 19, 2026-1 conv

SIVE (and POET) may become light source supplier for Google's TPU via MRVL's custom ASIC, using Celestial IP Photonic Fabric, with multi-year catalyst past 2028.

source β†—
πŸ“
updatedApr 22, 2026

POET's purchase orders and Marvell supplier relationships confirm strong demand, which translates to material benefit for SIVE's laser production. Markets haven't fully priced in either yet.

source β†—
πŸ“
updatedApr 25, 2026

Photonics supercycle with multiple architectural shifts. Beneficiaries include LITE, COHR for current cycle (still 50%+ upside), AAOI and JBL for transitional bridge, SIVE and POET for CPO future, AXTI for all cycles, and ALMU for future quantum dot packaging.

source β†—
πŸ“
updatedApr 26, 2026

AI hyperscaler demand is causing widespread supply chain bottlenecks across semiconductors, materials, and infrastructure components, benefiting companies exposed to CPUs, semiconductor equipment, photoresists, grid components, optical modules, and photonics.

source β†—
πŸ“
updatedApr 27, 2026

Marvell cancelled POET purchase orders after CFO violated NDA, highlighting single customer concentration risk for POET.

source β†—
πŸ“
updatedApr 27, 2026

MRVL will likely design out POET for interposer packaging and instead buy lasers from LITE or SIVE, doing packaging in-house, which is negative for POET.

source β†—
πŸ“
updatedApr 27, 2026

POET's recent reaction (likely stock drop) is not an overreaction due to single source customer concentration risk.

source β†—
πŸ“
updatedApr 27, 2026+1 conv

POET is at risk of being designed out by MRVL because POET only buys and packages lasers, and MRVL can go directly to laser sources, causing delays to POET's roadmap.

source β†—
πŸ“
updatedApr 27, 2026

Metaphor describing supply chain for optical components: SIVE and LITE produce specialized components (blue/red lobsters), POET processes them, MRVL integrates and sells. Nvidia buying red lobsters (alternative supply) may push MRVL to buy directly from SIVE/LITE, bypassing POET. The situation is fluid.

source β†—
πŸ“
updatedMay 15, 2026+2 conv

Post argues that FOCI is undervalued compared to POET, highlighting FOCI's critical role as bottleneck for CPO volume ramp and main supplier to TSM and NVDA, expecting outperformance once institutions discover it.

source β†—